Treating Chronic Lymphocytic Leukemia (CLL): A CALQUENCE™ Connections Event

0 Views

07/08/23

Full Prescribing Information https://bit.ly/32ycnxx

Watch the CALQUENCE™ Connections Panel Event – a moderated discussion brought to you by AstraZeneca and Cure® Magazine.

Jim, a real patient, along with his care team shares his CLL story, discusses how he and his wife manage his treatment, talks about how he keeps a positive attitude, and more.

Select Safety Information
CALQUENCE is a prescription oral treatment for adults with chronic lymphocytic leukemia or small lymphocytic lymphoma. May cause serious side effects including: serious infections, bleeding problems, decrease in blood cell count, new cancers, and heart rhythm problems. Some may lead to death. Tell your doctor if you experience infections such as flu-like symptoms; unexpected bleeding such as blood in your stool or urine; or heart rhythm problems such as fast or irregular heartbeat. Use sun protection when outside.

CALQUENCE is a registered trademark of the AstraZeneca group of companies.
©2021 AstraZeneca. All rights reserved.
US-54800 Last Updated 6/21

Chapters:
0:00 - Intro

1:06 - About CALQUENCE® (acalabrutinib)

2:56 - Understanding Chronic Lymphocytic Leukemia (CLL)

8:40 - A Patient’s View on Navigating the Healthcare System: Jim’s Story

11:09 - The Role of Support Services and Programs

16:17 - Recent Developments in Treatment for CLL

19:15 - Communicating with Your Care Team

21:13 - Finding a Treatment for CLL

25:41 - Expectations and Outcomes from Treatment

28:15 - Advice & Recommendations for Those Recently Diagnosed with CLL

38:20 - Q&A

47:25 - CALQUENCE Efficacy, Dosing and Important Safety Information